These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3111903)

  • 21. Antigen load governs the differential priming of CD8 T cells in response to the bacille Calmette Guerin vaccine or Mycobacterium tuberculosis infection.
    Ryan AA; Nambiar JK; Wozniak TM; Roediger B; Shklovskaya E; Britton WJ; Fazekas de St Groth B; Triccas JA
    J Immunol; 2009 Jun; 182(11):7172-7. PubMed ID: 19454714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Attempts at isolation and characterization of immunogenically active fractions from Mycobacterium tuberculosis and Mycobacterium bovis (BCG). IV. Immunobiologic properties of the fractions].
    Klose F; Schallehn G
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Sep; 131(3):219-35. PubMed ID: 4231180
    [No Abstract]   [Full Text] [Related]  

  • 24. Mycobacterial antibodies after tuberculin testing, BCG- vaccination, BCG-immunotherapy and against cross-reacting antigens in a solid-phase radioimmunoassay.
    Mauch H; Brehmer W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Mar; 251(3):380-8. PubMed ID: 6805156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Investigation of the thermal resistance of Mycobacteria tuberculosis].
    Lysenko AP; Lemish AP; Krasnikova EL; Arkhipov IN; Vlasenko VV; Vlasenko IG; Garbaccio S; Vasil'ev AN; Petrik OA; Sapsaĭ VI; Vasil'eva IG; Pritychenko AN; Rubnikovich TP
    Probl Tuberk Bolezn Legk; 2007; (2):42-6. PubMed ID: 17419335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Properties of TAS-1D3, a tuberculin-active substance from BCG, in regard to delayed hypersensitivity.
    Yano O; Toizumi S; Sudo T
    Microbiol Immunol; 1984; 28(10):1149-57. PubMed ID: 6441106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Purification, characterization and immunological study of 2 protein antigens of the BCG strain Mycobacterium bovis].
    De Bruyn J; Turneer M
    Bull Mem Acad R Med Belg; 1988; 143(1-2):157-70. PubMed ID: 3052672
    [No Abstract]   [Full Text] [Related]  

  • 28. Application of transdermal patches with new skin test reagents for detection of latent tuberculosis.
    Kasempimolporn S; Areekul P; Thaveekarn W; Sutthisri R; Boonchang S; Sawangvaree A; Sitprija V
    J Med Microbiol; 2019 Sep; 68(9):1314-1319. PubMed ID: 31274404
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical evaluation of the recombinant 38 kDa protein of Mycobacterium tuberculosis.
    He XY; Luo YA; Zhang XG; Liu YD; Wang ZY; Luo FZ; Zhang JP; Wang Q; Yan SM; Wang YJ; Ma LF; Guo J; Dong YJ; Huang XY; Zhuang YH
    Scand J Infect Dis; 2008; 40(2):121-6. PubMed ID: 17852901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
    Sugawara I; Udagawa T; Taniyama T
    Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production and characterization of monoclonal antibodies to Mycobacterium tuberculosis, M. bovis (BCG) and M. leprae.
    Kolk AH; Ho ML; Klatser PR; Eggelte TA; Kuijper S; de Jonge S; van Leeuwen J
    Clin Exp Immunol; 1984 Dec; 58(3):511-21. PubMed ID: 6439449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Model of allergy of the immediate type to BCG and analysis of allergic reactivity in BCG vaccination in experiments].
    Beklemishev ND; Sukhodoeva GS; Bul'vakhter IaL
    Probl Tuberk; 1975; (12):53-8. PubMed ID: 768978
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antigen L, a new antigen from tubercle bacilli active in delayed hypersensitivity in animals sensitized with living bacilli (B.C.G.)].
    Romain F; Augier-Gibory S; Versmisse E; Augier J
    C R Seances Acad Sci III; 1981 Nov; 293(11):631-3. PubMed ID: 6800581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunological properties of cellular membranes of Mycobacterium bovis].
    Romanova RIu; Pavlova VT; Il'ina IN; Kliuev VA
    Probl Tuberk; 1978 Aug; (8):67-70. PubMed ID: 360207
    [No Abstract]   [Full Text] [Related]  

  • 35. Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine.
    Jackson M; Phalen SW; Lagranderie M; Ensergueix D; Chavarot P; Marchal G; McMurray DN; Gicquel B; Guilhot C
    Infect Immun; 1999 Jun; 67(6):2867-73. PubMed ID: 10338493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MTSA-10, the product of the Rv3874 gene of Mycobacterium tuberculosis, elicits tuberculosis-specific, delayed-type hypersensitivity in guinea pigs.
    Colangeli R; Spencer JS; Bifani P; Williams A; Lyashchenko K; Keen MA; Hill PJ; Belisle J; Gennaro ML
    Infect Immun; 2000 Feb; 68(2):990-3. PubMed ID: 10639479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzymatic and antigenic analyses of strains of Mycobacterium bovis, M. bovis BCG, and M. tuberculosis.
    Ohman R; Ridell M
    Curr Microbiol; 1995 Mar; 30(3):161-5. PubMed ID: 7765849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody response to Mycobacterium tuberculosis antigens in children with pulmonary tuberculosis and in BCG vaccinated non tuberculous pediatric patients.
    López de Arcila C; Arcila-Castaño LE; Sosa de Martínez C; Pérez-Fernández L; García-Latorre E
    Rev Latinoam Microbiol; 1995; 37(2):161-9. PubMed ID: 8552876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.